BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1520354
Paris, I0
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$196,794,922
-$1,185,857 QoQ
Shares Held
1,493,813
+7.0% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $407,067,928 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (48.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,493,813 | $196,794,922 | |
| 2 | ZTS |
Zoetis Inc.
|
1,034,115 | $122,242,733 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
72,715 | $43,118,539 | |
| 4 | VTRS |
Viatris Inc
|
1,108,006 | $14,969,159 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
391,587 | $11,794,600 | |
| 6 | ALKS |
Alkermes plc.
|
239,671 | $8,474,765 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
683,997 | $3,693,583 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
117,894 | $2,664,403 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $196,794,922 | 1,493,813 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $197,980,779 | 1,395,902 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $133,084,871 | 948,033 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $129,749,282 | 1,032,296 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $138,814,721 | 1,255,106 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $128,956,736 | 944,738 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $94,476,712 | 819,968 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $107,777,711 | 782,870 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $108,983,417 | 790,193 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $94,945,333 | 720,593 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $76,312,124 | 678,330 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,957,174 | 657,022 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $62,012,837 | 612,654 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $65,854,079 | 551,357 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $56,663,671 | 533,506 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $43,653,201 | 447,817 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $33,654,093 | 358,977 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $31,733,660 | 372,592 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $37,572,742 | 391,750 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $38,241,115 | 392,942 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $31,456,485 | 323,460 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $24,732,079 | 258,029 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $25,376,239 | 263,896 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $27,005,066 | 221,353 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $20,415,760 | 235,884 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||